Sharp Packaging Services, a unit of UDG Healthcare, has acquired Daiichi Sankyo’s pharmaceutical packaging facility in Bethlehem, Pennsylvania, US for $14m.
The acquisition of 146,000ft2 pharmaceutical grade packaging facility is a part of Sharp’s growth and capacity expansion plan to support new and existing customers.
The facility will allow the company to offer additional serialization options to customers in bottling, blistering and C-II packaging, as well as extended redundancy and risk mitigation.
Inspected by the US Food and Drug Administration (FDA) and approved by Drug Enforcement Administration (DEA), the facility features two high speed bottle lines, two blister lines, cold and frozen storage, office space and a 2,500ft2 analytical laboratory.
Daiichi Sankyo administrative and commercial president Ken Keller said: “Selling the Plant to an organization that can maximize the facility is also the best long-term solution for our customers, our company, and the viability of the Plant.
“With its track record as a leader in contract packaging and clinical supply services for pharmaceutical companies, as well as its expertise in implementing serialization solutions, Sharp is the right partner to assume our packaging operations.”
The Bethlehem facility has further development potential to expand to 235,000ft.
Ken Keller added: “Given Sharp Packaging Services’ excellent track record and expertise in delivering commercial and clinical packaging solutions, we are delighted for both our customers and employees that Sharp have secured the long-term future of the Bethlehem packaging facility.”
The sale is a part of Daiichi Sankyo’s plans to focus towards the specialized areas of oncology and pain and use outsourced packaging model for its medications.